Guided Therapeutics Inc. (OTCMKTS:GTHP) Shares Shorted: Short Interest Up 55.0% in September

Guided Therapeutics Inc. (OTCMKTS:GTHP) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 6,822 shares, a growth of 55.0% from the August 31st total of 4,400 shares. Based on an average daily volume of 19,766 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the shares of the stock are sold short.

Guided Therapeutics Stock Performance

Shares of GTHP stock opened at $0.25 on Friday. The stock has a fifty day moving average price of $0.25 and a 200 day moving average price of $0.24. The stock has a market cap of $23.93 million, a PE ratio of -6.20 and a beta of 0.69. Guided Therapeutics has a 1 year low of $0.15 and a 1 year high of $0.54.

Guided Therapeutics (OTCMKTS:GTHP) last posted its earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc is a medical technology company focused on developing diagnostic products for the detection of cancer and precancerous conditions. Its technology is based on biophotonic tissue analysis, which uses light to identify changes in tissue that may be associated with disease.

The company’s principal product is LuViva Advanced Cervical Scan, a noninvasive diagnostic device designed to evaluate cervical tissue for abnormalities associated with cervical cancer and precancer.